Health Cor Management, L.P. Alnylam Pharmaceuticals, Inc. Transaction History

Health Cor Management, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$159.56 - $209.29 $1.2 Million - $1.57 Million	-7,510 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$169.75 - $207.73 $1.27 Million - $1.56 Million	7,510 New	7,510 $1.42 Million
Q3 2019 Nov 14, 2019	SELL	$70.9 - $87.82 $33.2 Million - $41.1 Million	-468,540 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$65.86 - $92.79 $30.9 Million - $43.5 Million	468,540 New	468,540 $34 Million

644

109M

1.28M

1.21M

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $31.3B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

Get notified when there are updates to the investment portfolio of Health Cor Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Health Cor Management, L.P. with notifications on news.